Menú

GRenSSAP
GRenSSAP

Group leader
avatar_investigadors.jpg
Anna Berenguera Ossó
avatar_grups_recerca.png

Projectes

Group projects

Teze Cardiac PASS – SIDIAP Feasibility Questionnaire

  • Principal investigators: Maria Giner Soriano, Maria Giner Soriano
  • Code: 9F-0-00058-23
  • Start year: 2023
  • Funders: IQVIA LTD

Safety of Paxlovid during pregnancy (C4671037, VAC4EU & SIGMA study)

  • Principal investigators: Maria Giner Soriano
  • Code: 4RNC-0-00181-23
  • Start year: 2023
  • Funders: Research Triangle Institute (RTI)

Safety of Paxlovid among patients with moderate or severe hepatic or renal impairment (C4671047, VAC4EU & SIGMA study)

  • Principal investigators: Maria Giner Soriano
  • Code: 4RNC-0-00182-23
  • Start year: 2023
  • Funders: Research Triangle Institute (RTI)

Study protocol for the Teratogenic Drugs Prioritisation (TDP) project combining pre-clinical data with clinical data from ConcePTION data sources (task 7.9)

  • Principal investigators: Maria Giner Soriano
  • Code: 4RNC-0-00095-24
  • Start year: 2024

A Drug Utilization Study to Evaluate the Effectiveness of Risk Minimization Measures (RMMs) for Abrocitinib in the EU Using Electronic Healthcare Data

  • Principal investigators: Rosa Morros Pedrós, Maria Giner Soriano
  • Code: 4RNC-0-00211-24
  • Start year: 2024